AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Asthma and Antibiotic Use May Predict Nasal Polyp Recurrence After Endoscopic Sinus Surgery Feb. 4, 2025 — The probability of revision sinus surgery including the removal of nasal polyps is ...

Labelling warns that certain nasal conditions, such as nasal polyps or a history of nasal surgery, may affect the absorption of the new drug. ARS said it will launch the product onto the market ...

Post-nasal drip treatments include rinsing your sinuses, using steam, avoiding allergens, and addressing the underlying cause. If your post-nasal drip symptoms don't go away, you may need to see a ...

In Phase III MINT trial, Uplizna (inebilizumab) demonstrated significant short-term efficacy and a manageable safety profile in adult patients with generalized myasthenia gravis, offering a promising ...